... and 65, much of which is the result of women reaching menopause. With the number of Australians aged 50-65 increasing each year, this is fuelling the growth of calming and sleeping products. Euromonitor International's Calming ...  |  read more...

... With Australians worried about developing arthritis more than any other disease, brand operators have focused on developing more effective products for the relief of arthritic pain. For example Panadol Osteo from GlaxoSmithKline Australia Pty Ltd ...  |  read more...

... population. Both children and the elderly have sensitive skin, and are susceptible to allergies and skin conditions, thus the category is benefiting from this Euromonitor International's Dermatologicals in Australia report offers a comprehensive guide to ...  |  read more...

... supplements all perform more strongly than during the review period. The performance of these categories combined ensured robust sales for consumer health in Australia. Euromonitor International's Consumer Health in Australia report offers a comprehensive guide ...  |  read more...

... increasing switch from prescription to OTC drugs. The OTC Pharmaceuticals market in the APAC region has also been witnessing the trend of an increasing number of mergers and acquisitions. However, the product recalls by the ...  |  read more...

... coupled with lacklustre growth in the economy. On the upside, eldercare providers (hospitals, medical devices suppliers and pharmaceutical firms) will see growth opportunities due to the ageing population. In addition, we note that generic drug ...  |  read more...

... research report, the low operating costs and skilled manpower continue to attract pharmaceutical companies towards Asia Pacific, which is now emerging as a powerhouse of pharmaceutical Research & Development (R&D). The future of the industry ...  |  read more...

... and minerals. It excludes products which require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for OTC Pharmaceuticals in New Zealand is given in ...  |  read more...

... products that help to provide a good night’s sleep. Steady growth also points to the fact that an increasing number of individuals have busy and stressful lives and that sleeping disorder incidence is on the ...  |  read more...

... growth drivers to boost value sales during the year. Euromonitor International's Ear Care in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides ...  |  read more...

... companies. However, regulatory hurdles, patent litigation and east versus west cultural differences pose important challenges to gaining access to the largest region in the world. Euromonitor International’s Regional Overview: Consumer Health Trends in Asia Pacific ...  |  read more...

... reclassify these two drugs considering the fact they are active ingredients used in the manufacture of the Class A controlled drug methamphetamine. Prior to the reclassification, pseudoephedrine was available over the counter in cold and ...  |  read more...

... result of this reclassification, three different triptan products were commonly available, Sumagran Active, Imigran and Arrow Sumatriptan. In May 2010, Pharmac announced that it would stop subsidising Imigran and Sumagran Active and begin subsidising Arrow-Sumatriptan ...  |  read more...